MPD: List measures where strain WSB/EiJ is an outlier

List measures where WSB/EiJ is an outlier

Click on pulldowns below to see WSB/EiJ means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Auwerx2:47	Auwerx2	monitoring system	(none)	carbon dioxide production, 24h test, night time average [mL/kg/min] vco2_night 114575 CD HFD	inbred w/CC8	9	both	14wks	N=4	2021

Auwerx2:79	Auwerx2	body temperature	(none)	body temperature (rectal) in cold (4°C) room, 0h exposed to cold [°C] temp_t0 114607 CD HFD	inbred w/CC8	9	both	18wks	N=4	2021

Auwerx2:105	Auwerx2	monitoring system	(none)	basal oxygen consumption, prior to treadmill test [mL/kg/min] vo2_basal 114633 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:113	Auwerx2	monitoring system	(none)	maximum oxygen consumption, treadmill test [ratio] vo2_max_treadmill 114641 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:115	Auwerx2	monitoring system	(none)	maximum carbon dioxide production, treadmill test [mL/kg/min] vco2_max_treadmill 114643 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:119	Auwerx2	treadmill endurance test	(none)	distance traveled, treadmill test [m] dist_treadmill 114647 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Auwerx2:143	Auwerx2	metabolic panel	(none)	plasma alanine transaminase amount (ALAT) [U/L] ALAT 114671 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:145	Auwerx2	metabolic panel	(none)	plasma aspartate transaminase amount (ASAT) [U/L] ASAT 114673 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:151	Auwerx2	metabolic panel	(none)	plasma lactate dehydrogenase amount (LDH) [U/L] LDH 114679 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Bopp1:1	Bopp1	health assessment	Plasmodium berghei	survival, post-infection [d] survival 36401	inbred	31	both	8-12wks	N=4	2010

CGDpheno1:56	CGDpheno1	metabolic panel	(none)	potassium (plasma K) [mmol/L] potassium 31856	inbred w/CC8	72	both	12wks	N=8	2009

CGDpheno1:89	CGDpheno1	body size and weight	(none)	body length (tip of nose to base of tail) [cm] bodylength 31889	inbred w/CC7	71	both	13wks	N=7	2009

CGDpheno3:15	CGDpheno3	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 43915	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:17	CGDpheno3	complete blood count	(none)	mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 43917	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:18	CGDpheno3	complete blood count	(none)	RBC corpuscular hemoglobin concentration mean (CHCM) [g/dL] CHCM 43918	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:19	CGDpheno3	complete blood count	(none)	hemoglobin concentration distribution width (HDW) [g/dL] HDW 43919	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:22	CGDpheno3	complete blood count	(none)	hematocrit (HCT) [%] HCT 43922	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:40	CGDpheno3	DXA	(none)	whole body bone mineral density (BMD) [g/cm²] BMD 43940	CC diallel w/par	62	both	16wks	N=5	2012

CGDpheno3:41	CGDpheno3	DXA	(none)	whole body bone mineral content (BMC) [g] BMC 43941	CC diallel w/par	62	both	16wks	N=5	2012

Chesler2:28	Chesler2	colony observation	(none)	number of mice born in first litter [n] litter_size 43441	CC diallel w/par	62	both	4wks	N=8	2011

Chesler2:30	Chesler2	colony observation	(none)	time from mate to first litter [d] duration_to_litter 43443	CC diallel w/par	62	both	4wks	N=8	2011

Chesler2:50	Chesler2	behavior observation	(none)	response to capture [score] capture_score 43470	CC diallel w/par	62	both	7-15wks	N=8	2011

Chesler2:51	Chesler2	behavior observation	(none)	response to holding [score] hold_score 43471	CC diallel w/par	62	both	7-15wks	N=8	2011

Chesler2:52	Chesler2	behavior observation	(none)	capture and hold scores combined [score] wildness_score 43472	CC diallel w/par	62	both	7-15wks	N=8	2011

Chesler2:54	Chesler2	nociception assay	(none)	latency of nociceptive response to hot plate (54°C), 30 s test [s] hot_plate 43474	CC diallel w/par	56	both	7-15wks	N=3	2011

Chesler3:70	Chesler3	behavior observation	(none)	response to capture [score] capture_score 43570	CC pre w/par	350	both	7-15wks	N=2	2011

Chesler3:71	Chesler3	behavior observation	(none)	response to holding [score] hold_score 43571	CC pre w/par	350	both	7-15wks	N=2	2011

Chesler3:72	Chesler3	behavior observation	(none)	capture and hold scores combined [score] wildness_score 43572	CC pre w/par	350	both	7-15wks	N=2	2011

Crowley1:12	Crowley1	open field test	haloperidol	distance traveled, 60 min test [cm] horizontal_act 39412 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:25	Crowley1	open field test	haloperidol	center occupancy, percentage of total time [%] pct_center 39425 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

CSNA03:31	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), CC [cm] amb_dist_OFT_cc 90020 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:107	CSNA03	open field test	(none)	time in corners, 60 min test (OFT), CC [s] time_corner_OFT_cc 90107	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:203	CSNA03	light-dark box	(none)	total time, 20 min test (LD box), CC [s] time_tot_LD_cc 90203	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:266	CSNA03	hole board test	(none)	total number of entries (hole board), CC [n] entries_total_HB_cc 90266	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:272	CSNA03	hole board test	(none)	number of repeat entries (hole board), CC [n] entries_repeat_HB_cc 90272	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:307	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, founders [cm] dist_d3_d2_cocaine_in 90307	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:309	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d3_d2_cocaine_do 90309	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:310	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, founders [cm] dist_d5_d3_cont_in 90310	inbred w/CC8	9	both	8-14wks	N=6	2018

CSNA03:311	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, CC [cm] dist_d5_d3_cont_cc 90311	CC w/par	58	both	8-21wks	N=3	2018

CSNA03:312	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, DO [cm] dist_d5_d3_cont_do 90312	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:327	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, DO [cm] dist_d19_d11_cocaine_do 90327	DO population w/par	9	both	8-21wks	N=23	2018

CSNA03:329	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, CC dist_d3_d11_auc_cont_cc 90438	CC w/par	58	both	8-21wks	N=3	2018

CSNA03:361	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders [cm] dist_f30_cocaine_in 90331 day: 1 2 3 5 7 9 11 12 19	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:370	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC [cm] dist_f30_cocaine_cc 90332 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:397	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, CC [cm] dist_l60_cont_cc 90383 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:424	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC [cm] dist_l60_cocaine_cc 90386 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:470	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO [n] infusions_do 110262 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	DO population w/par	9	both	4-25wks	N=73	2018

CSNA03:647	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_Binghamton 112873 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:653	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_Binghamton 112875 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:692	CSNA03	in vitro assay	(none)	peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, CC [n/s] amplitude_cc 112546	CC w/par	40	both	8-12wks	N=4	2020

Donahue18:4	Donahue18	colony observation	(none)	percentage of pups that survived to day 3 [%] pup_survival 44404	inbred	15	f	6-8wks	N=17	2010

GMC03:4	GMC03	observation (SHIRPA)	(none)	body position (0=inactive, 1=active, 2=excessively active) [score] body_pos 55213	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC03:8	GMC03	observation (SHIRPA)	(none)	defecation (0=present, 1=absent) [score] defecation 55221	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC03:12	GMC03	observation (SHIRPA)	(none)	evidence of biting (0=not aggressive, 1=aggressive) [score] bite_evidence 55225	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC03:13	GMC03	observation (SHIRPA)	(none)	vocalization (0=no, 1=yes) [score] vocalization 55226	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC03:21	GMC03	observation (SHIRPA)	(none)	touch escape (0=no response, 1=response to touch, 2=flees prior to touch) [score] touch_escape 55251	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC05:11	GMC05	acoustic startle test	(none)	acoustic startle response (ASR) [amplitude] ASR 55411 background noise 70dB 80dB 85dB 90dB 100dB 110dB 120dB	inbred w/CC8	8	both	9-10wks	N=17	2018

GMC07:11	GMC07	nociception assay	(none)	latency of nociceptive response to hot plate [s] latency 55611 reaction1 reaction2	inbred w/CC8	8	both	11-12wks	N=17	2018

Harrill1:1	Harrill1	body weight	(none)	body weight day 1 [g] bw_d1 39501 control group treatment group	inbred	34	f	8-10wks	N=4	2011

Harrill1:3	Harrill1	body weight	isoniazid	body weight day 4 [g] bw_d4 39503 control isoniazid	inbred	33	f	8-10wks	N=4	2011

Harrill1:5	Harrill1	organ weights	isoniazid	liver weight [g] liver 39505 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:11	Harrill1	organ weights	isoniazid	spleen weight [g] spleen 39511 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill2:11	Harrill2	metabolic panel	DB289	alanine transaminase (serum ALT) [IU/L] ALT 44111 control DB289 difference	inbred	34	f	6-8wks	N=5	2012

Harrill2:15	Harrill2	metabolic panel	DB289	blood urea nitrogen (serum BUN) [mg/dL] BUN 44115 control DB289 difference	inbred	34	f	6-8wks	N=5	2012

Harrill2:21	Harrill2	metabolic panel	DB289	creatinine (serum CREA) [mg/dL] serum_CREA 44121 control DB289 difference	inbred	34	f	6-8wks	N=5	2012

Harrill2:51	Harrill2	organ weights	DB289	total kidney weight as percentage of body weight [%] pctKW_BW 44151 control DB289 difference	inbred	34	f	6-8wks	N=5	2012

Harrill2:61	Harrill2	organ weights	DB289	liver weight at sacrifice [g] LW 44161 control DB289	inbred	34	f	6-8wks	N=5	2012

Korstanje1:1	Korstanje1	urinalysis	(none)	microalbumin (urine MA) [mg/dL] MA 29701 12mo 18mo 24mo	inbred	30	both		N=7	2008

Korstanje1:21	Korstanje1	urinalysis	(none)	albumin-creatinine ratio (urine ACR) [mg/g] ACR 29721 12mo 18mo 24mo	inbred	30	both		N=7	2008

Kumar3:10	Kumar3	open field test	(none)	distance traveled in first 5 min [cm] OFDistTraveled5m 112918	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:11	Kumar3	open field test	(none)	distance traveled in first 20 min [cm] OFDistTraveled20m 112919	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:12	Kumar3	open field test	(none)	distance traveled in first 55 min [cm] OFDistTraveled55m 112920	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:21	Kumar3	open field test	(none)	time spent grooming first 55 min [s] GrTime55m 112929	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:29	Kumar3	open field test	(none)	duration of grooming events first 55 min (s per event) [s/n] GrBoutLength55m 112937	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:30	Kumar3	open field test	(none)	average duration of grooming events first 55 min divided by 55 GrBoutLengthSlope55m 113846	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:32	Kumar3	open field test	(none)	amount of time spent grooming when animal grooms most (in 5 min range) [s] GrPeakVal 113848	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar4:26	Kumar4	gait analysis	(none)	lateral distance separating hind paws (keypoints), mean [cm] step_width_mean 114456	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:27	Kumar4	gait analysis	(none)	lateral distance separating hind paws (keypoints), median [cm] step_width_median 114457	inbred w/CC8	62	both	10-20wks	N=19	2021

Lightfoot1:3	Lightfoot1	running wheel monitoring	(none)	wheel running activity, mean speed [m/min] activity_speed 35703	inbred	41	both	8-16wks	N=6	2010

Lightfoot1:80	Lightfoot1	colony observation	(none)	age at testing (local parameter) [d] age 35780	inbred	41	both		N=6	2010

Loos2:7	Loos2	home cage monitoring	(none)	habituation ratio describing change in cumulative activity duration, over 3 days of testing, log10 transformed [log(ratio)] activity_dur_hab 54007 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Mathes1:1	Mathes1	body weight	exercise	body weight [g] bw 45201 before exercise after exercise difference	CC pre w/par	184	m	10-12wks	N=1	2011

Naggert1:2	Naggert1	metabolic panel	high-fat diet	glucose (plasma GLU, 4h fast) [mg/dL] GLU 14302 baseline after 17wks on diet Δchange	inbred w/CC7	43	both	7-9wks	N=10	2003

Odet1:24	Odet1	histopathology	(none)	number of seminiferous tubules with vacuoles, transverse section [n] seminif_vacuoles 53724	inbred w/CC8	8	m	10-66wks	N=26	2015

Odet1:25	Odet1	histopathology	(none)	number of seminiferous tubules with many vacuoles, transverse section [n] seminif_many_vacuoles 53725	inbred w/CC8	8	m	10-66wks	N=26	2015

Odet2:21	Odet2	microscopy	(none)	percentage of motile sperm that are 'intermediate' [%] sperm_int 53821 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:61	Odet2	microscopy	(none)	sperm mean straight line velocity [µm/s] sperm_VSL 53861 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Odet2:94	Odet2	microscopy	(none)	sperm mean linearity [ratio] sperm_LIN 53894 min: 10 30 60 90 120	inbred w/CC8	8	m	10-66wks	N=13	2015

Paigen1:5	Paigen1	body weight	high-fat diet	body weight [g] bw 2905 start after 8wks on diet fold change	inbred	43	both	7-11wks	N=12	2000

Paigen1:24	Paigen1	metabolic panel	high-fat diet	alanine transaminase (plasma ALT) [IU/L] ALT 2924	inbred	43	both	15-19wks	N=8	2000

Paigen1:26	Paigen1	lipid profile	high-fat diet	hepatic cholesterol concentration (free per g liver) [mg] freeHCC 2926	inbred	43	both	15-19wks	N=6	2000

Paigen1:27	Paigen1	lipid profile	high-fat diet	hepatic cholesterol concentration (esterified per g liver) [mg] estHCC 2927	inbred	43	both	15-19wks	N=6	2000

Paigen1:28	Paigen1	lipid profile	high-fat diet	hepatic cholesterol concentration (total per g liver) [mg] totHCC 2928	inbred	43	both	15-19wks	N=8	2000

Paigen2:5	Paigen2	lipid profile	high-fat diet	non-HDL cholesterol (plasma) [mg/dL] nonHDL 9905 baseline after 17wks on diet Δchange	inbred w/CC7	42	both	7-9wks	N=9	2002

Peters1:17	Peters1	complete blood count	(none)	reticulocyte differential (percent of total RBC) [%] Retic 6217	inbred w/CC7	43	both	10wks	N=12	2001

Peters4:21	Peters4	complete blood count	(none)	eosinophil count (EOS; units per volume x 10³) [n/µL] EOS 24321 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:29	Peters4	complete blood count	(none)	large unstained cells count (LUC; units per volume x 10³) [n/µL] LUC 24329 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:45	Peters4	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 24345 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:53	Peters4	complete blood count	(none)	large unstained cells differential (LUC; percentage of total WBC) [%] pctLUC 24353 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:69	Peters4	complete blood count	(none)	mean RBC hemoglobin concentration (MCHC) [g/dL] MCHC 24369 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:93	Peters4	complete blood count	(none)	platelet count (PLT; units per volume x 10³) [n/µL] Plt 24393 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Petkova1:16	Petkova1	immune cell quantification	(none)	eosinophil differential (EOS; percentage of total WBC) [%] EOS 24216 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Rusyn2:17	Rusyn2	metabolic panel	trichloroethylene	alanine transaminase (serum ALT), treated group [IU/L] ALT_tce 36117 time: 2h 8h 24h	inbred	17	m	7wks	N=3	2010

Rusyn2:37	Rusyn2	metabolic panel	trichloroethylene	blood urea nitrogen (serum BUN), treated group [mg/dL] BUN_tce 36137 time: 2h 8h 24h	inbred	16	m	7wks	N=3	2010

Rusyn5:58	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Cebpa, mRNA abundance relative to high-fat-only group [%] liver_Cebpa_hfe 43058	inbred	14	m	8-14wks	N=3	2011

Seburn2:1	Seburn2	grip strength	(none)	grip strength, peak tension over 3 trials [g] grip_strength 24801 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2008

Tarantino2:31	Tarantino2	open field test	ovariectomy	distance traveled in periphery of arena, 10 min test [cm] OFT_thigmotaxis 50631 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tordoff3:14	Tordoff3	bottle choice test	(none)	preference for NaCl (sodium chloride) solutions [%] NaCl_pref 10314 concentration (mM): 25 75 225	inbred w/CC7	40	both	11-13wks	N=10	2002

Tordoff3:17	Tordoff3	bottle choice test	(none)	preference for NaLa (sodium lactate) solutions [%] NaLa_pref 10317 concentration (mM): 25 75 225	inbred w/CC7	40	both	12-14wks	N=10	2002

Tordoff3:25	Tordoff3	colony observation	(none)	age of mouse at death (local parameter) [d] age_end 10325	inbred w/CC7	40	both		N=10	2002

Wiltshire4:7	Wiltshire4	immune cell quantification	BEZ235	T cells, percent viability [%] Tcells_BEZ 52407 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:13	Wiltshire4	immune cell quantification	BEZ235	monocytes, percent viability [%] monocytes_BEZ 52413 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:21	Wiltshire4	immune cell quantification	doxorubicin	B cells, percent viability [%] Bcells_Dox 52421 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:33	Wiltshire4	immune cell quantification	doxorubicin	monocytes, percent viability [%] monocytes_Dox 52433 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:41	Wiltshire4	immune cell quantification	idarubicin	B cells, percent viability [%] Bcells_Ida 52441 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:47	Wiltshire4	immune cell quantification	idarubicin	T cells, percent viability [%] Tcells_Ida 52447 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:53	Wiltshire4	immune cell quantification	idarubicin	monocytes, percent viability [%] monocytes_Ida 52453 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Yuan3:1	Yuan3	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 24401 6mo 12mo 18mo	inbred	32	both		N=6	2008

Yuan3:21	Yuan3	metabolic panel	(none)	chloride (serum Cl) [mmol/L] Cl 24421 6mo 12mo 18mo	inbred	32	both		N=7	2008

Yuan3:46	Yuan3	metabolic panel	(none)	sodium (serum Na) [mmol/L] Na 24446 6mo 12mo 18mo	inbred	32	both		N=7	2008

Yuan3:76	Yuan3	metabolic panel	(none)	thyroxine (serum T4) [µg/dL] T4 24476 6mo 12mo 18mo	inbred	32	both		N=7	2008

Zheng1:20	Zheng1	colony observation	(none)	animal age at test (local parameter) [wks] age 29820	inbred	61	both		N=4	2008

List measures where WSB/EiJ is an outlier

Filter Table Results